Transforming U.S. HIV Care with Long-Acting Injectables

This presentation examines the U.S. HIV long-acting injectable (LAI) market, highlighting its growth trajectory, the necessity for equitable healthcare solutions, and adoption challenges. It delves into market dynamics dominated by a few firms and a shift toward provider-based adherence models. Stakeholder impacts, including patient diversity, R&D by pharmaceutical firms, and challenges for underserved populations, are analyzed. Proposed strategies include tiered pricing, increased...